1. Home
  2. VCYT vs SUPN Comparison

VCYT vs SUPN Comparison

Compare VCYT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$34.88

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$49.32

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCYT
SUPN
Founded
2006
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
VCYT
SUPN
Price
$34.88
$49.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$46.00
$61.60
AVG Volume (30 Days)
824.1K
728.8K
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
N/A
Revenue
$495,141,000.00
$681,539,000.00
Revenue This Year
$16.72
$8.18
Revenue Next Year
$11.31
$22.15
P/E Ratio
$94.90
N/A
Revenue Growth
16.41
4.54
52 Week Low
$22.61
$29.16
52 Week High
$50.71
$57.65

Technical Indicators

Market Signals
Indicator
VCYT
SUPN
Relative Strength Index (RSI) 27.09 49.08
Support Level $40.29 $47.29
Resistance Level $38.98 $49.71
Average True Range (ATR) 1.84 1.37
MACD -0.64 -0.14
Stochastic Oscillator 0.14 57.82

Price Performance

Historical Comparison
VCYT
SUPN

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: